Compounds > mci-196
Page last updated: 2024-08-24

mci-196 and Phosphorus Metabolism Disorders

mci-196 has been researched along with Phosphorus Metabolism Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akizawa, T; Kurihara, S; Tsuruta, Y1
Bellasi, A; Block, GA; Kooienga, L1

Reviews

1 review(s) available for mci-196 and Phosphorus Metabolism Disorders

ArticleYear
Phosphate binders: new products and challenges.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2006, Volume: 10, Issue:3

    Topics: Aluminum; Bile Acids and Salts; Calcium; Humans; Lanthanum; Niacinamide; Phosphates; Phosphorus Metabolism Disorders; Polymers; Renal Dialysis

2006

Trials

1 trial(s) available for mci-196 and Phosphorus Metabolism Disorders

ArticleYear
Effect of MCI-196 (colestilan) as a phosphate binder on hyperphosphataemia in aemodialysis patients: a double-blind, placebo-controlled, short-term trial.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:2

    Topics: Bile Acids and Salts; Calcium; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Phosphorus Metabolism Disorders; Placebos; Renal Dialysis

2005